$SYNA
SYNAPTICS Inc

2020 Q2 Form 10-K Financial Statement

#000156459021045326 Filed on August 23, 2021

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q3 2019 Q2
Revenue $277.6M $339.9M $295.1M
YoY Change -5.93% -18.61% -24.04%
Cost Of Revenue $155.1M $213.7M $204.7M
YoY Change -24.23% -22.77% -21.54%
Gross Profit $122.5M $126.2M $90.40M
YoY Change 35.51% -10.43% -29.15%
Gross Profit Margin 44.13% 37.13% 30.63%
Selling, General & Admin $31.60M $27.90M $26.80M
YoY Change 17.91% -17.7% -30.21%
% of Gross Profit 25.8% 22.11% 29.65%
Research & Development $55.30M $3.700M $84.20M
YoY Change -34.32% -95.89% -6.65%
% of Gross Profit 45.14% 2.93% 93.14%
Depreciation & Amortization $15.80M $25.40M $26.40M
YoY Change -40.15% -15.33% -18.01%
% of Gross Profit 12.9% 20.13% 29.2%
Operating Expenses $89.80M $3.700M $113.9M
YoY Change -21.16% -97.08% -14.3%
Operating Profit $32.70M $3.200M -$23.50M
YoY Change -239.15% -77.3% 343.4%
Interest Expense -$5.300M -$3.200M -$6.800M
YoY Change -22.06% 68.42% 51.11%
% of Operating Profit -16.21% -100.0%
Other Income/Expense, Net $0.00 -$3.600M $2.800M
YoY Change -100.0% 89.47%
Pretax Income $111.8M -$400.0K -$37.30M
YoY Change -399.73% -110.26% 182.58%
Income Tax $21.30M $4.900M $8.400M
% Of Pretax Income 19.05%
Net Earnings $90.00M $4.000M -$46.20M
YoY Change -294.81% 5.26% 2980.0%
Net Earnings / Revenue 32.42% 1.18% -15.66%
Basic Earnings Per Share $0.12
Diluted Earnings Per Share $2.521M $0.12 -$1.347M
COMMON SHARES
Basic Shares Outstanding 33.00M 34.50M
Diluted Shares Outstanding 33.60M

Balance Sheet

Concept 2020 Q2 2019 Q3 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $763.4M $350.8M $327.8M
YoY Change 132.89% 33.23% 8.9%
Cash & Equivalents $763.4M $350.8M $327.8M
Short-Term Investments
Other Short-Term Assets $16.90M $15.90M $14.60M
YoY Change 15.75% -50.16% -19.78%
Inventory $102.0M $138.2M $158.7M
Prepaid Expenses
Receivables $195.3M $232.2M $230.0M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.078B $737.1M $731.1M
YoY Change 47.39% -6.58% -1.14%
LONG-TERM ASSETS
Property, Plant & Equipment $84.30M $98.80M $103.0M
YoY Change -18.16% -10.91% -12.56%
Goodwill $360.8M $372.8M $372.8M
YoY Change -3.22% 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $77.70M $89.00M $58.10M
YoY Change 33.73% 68.24% 15.05%
Total Long-Term Assets $616.2M $687.2M $678.7M
YoY Change -9.21% -6.61% -10.73%
TOTAL ASSETS
Total Short-Term Assets $1.078B $737.1M $731.1M
Total Long-Term Assets $616.2M $687.2M $678.7M
Total Assets $1.694B $1.424B $1.410B
YoY Change 20.14% -6.59% -6.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $60.60M $99.00M $98.30M
YoY Change -38.35% -43.56% -37.35%
Accrued Expenses $150.5M $139.0M $136.5M
YoY Change 10.26% 11.38% 29.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $244.1M $247.5M $253.9M
YoY Change -3.86% -24.01% -10.54%
LONG-TERM LIABILITIES
Long-Term Debt $100.0M $472.8M $468.3M
YoY Change -78.65% 3.89% 3.91%
Other Long-Term Liabilities $44.00M $49.20M $30.30M
YoY Change 45.21% 45.13% -15.83%
Total Long-Term Liabilities $144.0M $49.20M $30.30M
YoY Change 375.25% -89.94% -15.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $244.1M $247.5M $253.9M
Total Long-Term Liabilities $144.0M $49.20M $30.30M
Total Liabilities $874.7M $769.5M $752.5M
YoY Change 16.24% -5.55% -2.34%
SHAREHOLDERS EQUITY
Retained Earnings $701.4M $583.5M
YoY Change 20.21% -3.78%
Common Stock $1.340B $1.278B $1.266B
YoY Change 5.85% 5.93%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.223B $1.209B $1.192B
YoY Change 2.53% 11.03%
Treasury Stock Shares
Shareholders Equity $819.1M $654.8M $656.4M
YoY Change
Total Liabilities & Shareholders Equity $1.694B $1.424B $1.410B
YoY Change 20.14% -6.59% -6.0%

Cashflow Statement

Concept 2020 Q2 2019 Q3 2019 Q2
OPERATING ACTIVITIES
Net Income $90.00M $4.000M -$46.20M
YoY Change -294.81% 5.26% 2980.0%
Depreciation, Depletion And Amortization $15.80M $25.40M $26.40M
YoY Change -40.15% -15.33% -18.01%
Cash From Operating Activities $53.50M $47.30M $43.40M
YoY Change 23.27% 928.26% 449.37%
INVESTING ACTIVITIES
Capital Expenditures -$4.600M $5.000M -$6.000M
YoY Change -23.33% -26.47% -9.09%
Acquisitions
YoY Change
Other Investing Activities $138.7M $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities $134.1M -$7.500M -$6.000M
YoY Change -2335.0% 87.5% -13.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $17.00M
YoY Change -56.85%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 103.5M -16.80M -33.50M
YoY Change -408.96% -56.02% -300.6%
NET CHANGE
Cash From Operating Activities 53.50M 47.30M 43.40M
Cash From Investing Activities 134.1M -7.500M -6.000M
Cash From Financing Activities 103.5M -16.80M -33.50M
Net Change In Cash 291.1M 23.00M 3.900M
YoY Change 7364.1% -161.01% -77.97%
FREE CASH FLOW
Cash From Operating Activities $53.50M $47.30M $43.40M
Capital Expenditures -$4.600M $5.000M -$6.000M
Free Cash Flow $58.10M $42.30M $49.40M
YoY Change 17.61% -2022.73% 240.69%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2021Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y1M6D
CY2020Q2 us-gaap Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List
OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiabilityNoncurrent
CY2020Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiability
CY2021Q2 us-gaap Operating Lease Liability Statement Of Financial Position Extensible List
OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList
us-gaap:OperatingLeaseLiability
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
000-49602
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
38854107
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0118518
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
1251 McKay Drive
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95131
CY2021 dei City Area Code
CityAreaCode
408
CY2021 dei Local Phone Number
LocalPhoneNumber
904-1100
CY2021 dei Security12b Title
Security12bTitle
Common Stock, par value $.001 per share
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Public Float
EntityPublicFloat
1921453072
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
763400000
CY2021Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5800000
CY2020Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5800000
CY2020Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
195300000
CY2020Q2 us-gaap Inventory Net
InventoryNet
102000000.0
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
16900000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
1077600000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84300000
CY2020Q2 us-gaap Goodwill
Goodwill
360800000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
93400000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
77700000
CY2020Q2 us-gaap Assets
Assets
1693800000
CY2020Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
60600000
CY2020Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
59500000
CY2020Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
33000000.0
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
91000000.0
CY2021Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
487100000
CY2021Q2 us-gaap Liabilities Current
LiabilitiesCurrent
786700000
CY2020Q2 us-gaap Liabilities Current
LiabilitiesCurrent
244100000
CY2021Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
394400000
CY2020Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
100000000.0
CY2020Q2 syna Convertible Notes Payable Net
ConvertibleNotesPayableNet
486600000
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
78500000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44000000.0
CY2021Q2 us-gaap Liabilities
Liabilities
1259600000
CY2020Q2 us-gaap Liabilities
Liabilities
874700000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
66963006
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65871648
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
35331903
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34122453
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
100000
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
100000
CY2021Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1391500000
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1340200000
CY2021Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
31631103
CY2020Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
31749195
CY2021Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1205400000
CY2020Q2 us-gaap Treasury Stock Value
TreasuryStockValue
1222600000
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
781000000.0
CY2020Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
701400000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
967200000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
819100000
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2226800000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1693800000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1333900000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1472200000
CY2020 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
790800000
CY2019 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
975100000
CY2020 us-gaap Gross Profit
GrossProfit
543100000
CY2019 us-gaap Gross Profit
GrossProfit
497100000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
302500000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
342700000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
127000000.0
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
131300000
CY2020 syna Amortization Of Intangible Assets Included In Operating Expense
AmortizationOfIntangibleAssetsIncludedInOperatingExpense
11700000
CY2019 syna Amortization Of Intangible Assets Included In Operating Expense
AmortizationOfIntangibleAssetsIncludedInOperatingExpense
11700000
CY2020 us-gaap Restructuring Charges
RestructuringCharges
33000000.0
CY2019 us-gaap Restructuring Charges
RestructuringCharges
17700000
CY2021 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
34200000
CY2021 us-gaap Operating Expenses
OperatingExpenses
464200000
CY2020 us-gaap Operating Expenses
OperatingExpenses
474200000
CY2019 us-gaap Operating Expenses
OperatingExpenses
503400000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
147000000.0
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
68900000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-6300000
CY2021 us-gaap Interest Income Other
InterestIncomeOther
2900000
CY2020 us-gaap Interest Income Other
InterestIncomeOther
7900000
CY2019 us-gaap Interest Income Other
InterestIncomeOther
3900000
CY2021 us-gaap Interest Expense
InterestExpense
29500000
CY2020 us-gaap Interest Expense
InterestExpense
22500000
CY2019 us-gaap Interest Expense
InterestExpense
21200000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-300000
CY2020 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
105100000
CY2019 us-gaap Gain Loss On Investments
GainLossOnInvestments
2800000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
120100000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
159400000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-20800000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31400000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38600000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9100000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2000000.0
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1800000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
79600000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
118800000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-22900000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.29
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.54
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.08
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.41
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33600000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34600000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34600000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
79600000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
118800000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-1500000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
118800000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-24400000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
26700000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
35600000
CY2021 syna Acquired Intangibles Amortization
AcquiredIntangiblesAmortization
110100000
CY2020 syna Acquired Intangibles Amortization
AcquiredIntangiblesAmortization
51400000
CY2019 syna Acquired Intangibles Amortization
AcquiredIntangiblesAmortization
74400000
CY2019 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-100000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25900000
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-31000000.0
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-53100000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
729300000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-22900000
CY2019 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1500000
CY2019 syna Payroll Taxes For Deferred Stock Units
PayrollTaxesForDeferredStockUnits
9400000
CY2019 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
118500000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
59000000.0
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
657300000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
118800000
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
34500000
CY2020 syna Payroll Taxes For Deferred Stock Units
PayrollTaxesForDeferredStockUnits
9700000
CY2020 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
30200000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
49300000
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
27800000
CY2021 syna Issuance Of Treasury Stock For Redemption Of Convertible Notes
IssuanceOfTreasuryStockForRedemptionOfConvertibleNotes
300000
CY2021 syna Payroll Taxes For Deferred Stock Units
PayrollTaxesForDeferredStockUnits
28300000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
69300000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
967200000
CY2021 us-gaap Profit Loss
ProfitLoss
79600000
CY2020 us-gaap Profit Loss
ProfitLoss
118800000
CY2019 us-gaap Profit Loss
ProfitLoss
-22900000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
66100000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
49300000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
59000000.0
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
21600000
CY2021 us-gaap Gain Loss On Sale Of Other Assets
GainLossOnSaleOfOtherAssets
34200000
CY2020 us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
105100000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
1200000
CY2021 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-300000
CY2020 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-2700000
CY2019 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
15200000
CY2021 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
19200000
CY2020 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
18300000
CY2019 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
17600000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
600000
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
600000
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
500000
CY2021 syna Amortization Of Cost Of Development Services
AmortizationOfCostOfDevelopmentServices
9200000
CY2019 us-gaap Gain Loss On Investments
GainLossOnInvestments
2800000
CY2020 us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2400000
CY2019 us-gaap Litigation Settlement Expense
LitigationSettlementExpense
-1900000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-9100000
CY2020 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-2000000.0
CY2019 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1800000
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3700000
CY2021 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
2800000
CY2020 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-400000
CY2020 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
100000000.0
CY2021 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
100000000.0
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-522600000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
119900000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-20900000
CY2021 us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
400000000.0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3600000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-3900000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-36200000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-55800000
CY2021 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
14900000
CY2020 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
29100000
CY2019 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
4900000
CY2019 syna Increase Decrease In Acquisition Related Liabilities
IncreaseDecreaseInAcquisitionRelatedLiabilities
-6800000
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-2100000
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
13800000
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
-17200000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
154200000
CY2020 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
138700000
CY2020 syna Payment To Acquire In Process Research And Development
PaymentToAcquireInProcessResearchAndDevelopment
2500000
CY2021 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
626500000
CY2021 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
34200000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
95800000
CY2019 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
2800000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21100000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16300000
CY2021 syna Payment For Cost Method Investment
PaymentForCostMethodInvestment
5000000.0
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
30200000
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
118500000
CY2021 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
27800000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
34500000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
21300000
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6100000
CY2020 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
700000
CY2021 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
19400000
CY2021 syna Payment For Payroll Taxes For Deferred Stock And Market Stock Units
PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits
28200000
CY2020 syna Payment For Payroll Taxes For Deferred Stock And Market Stock Units
PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits
9700000
CY2019 syna Payment For Payroll Taxes For Deferred Stock And Market Stock Units
PaymentForPayrollTaxesForDeferredStockAndMarketStockUnits
9400000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
274100000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
93900000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-106600000
CY2021 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2200000
CY2019 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
100000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
72900000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
435600000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
26800000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763400000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
327800000
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
301000000.0
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
836300000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
763400000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
327800000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
9600000
CY2020 us-gaap Interest Paid Net
InterestPaidNet
3700000
CY2019 us-gaap Interest Paid Net
InterestPaidNet
3600000
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
39700000
CY2020 us-gaap Income Taxes Paid
IncomeTaxesPaid
18900000
CY2019 us-gaap Income Taxes Paid
IncomeTaxesPaid
16400000
CY2021 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
300000
CY2020 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
1300000
CY2019 us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
6400000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
800000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1200000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with U.S. GAAP requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue, expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates, including those related to revenue, allowance for doubtful accounts, cost of revenue, inventories, loss on purchase commitments, product warranty, accrued liabilities, share-based compensation costs, provision for income taxes, deferred income tax asset valuation allowances, uncertain tax positions, goodwill, intangible assets, investments, and loss contingencies.  We base our estimates on historical experience, applicable laws and regulations, and various other assumptions that we believe to be reasonable under the circumstances, including our expectations regarding the potential impacts on our business of the COVID-19 pandemic, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.</p>
CY2021Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
0
CY2021Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2020Q2 us-gaap Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2020 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0
CY2021 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0
CY2021 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="text-align:justify;margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash equivalents, investments, and accounts receivable.  Our investment policy, which is predicated on capital preservation and liquidity, limits investments to U.S. government treasuries and agency issues, taxable securities, and municipal issued securities with a minimum rating of A1 (Moody’s) or P1 (Standard and Poor’s) or their equivalent.  </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We sell our products to contract manufacturers that provide manufacturing services for OEMs, to some OEMs directly, and to distributors.  We extend credit based on an evaluation of a customer’s financial condition, and we generally do not require collateral.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.86%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following customers accounted for more than 10% of our accounts receivable balance as of the end of fiscal 2021 and 2020:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;"> </p> <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer A</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer B</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18%</p></td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer C</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21%</p></td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> </tr> </table></div> <p style="border-bottom:Solid 1pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;margin-right:89.29%;text-indent:0%;font-size:6pt;font-family:Times New Roman;"> </p> <div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.57%;white-space:nowrap" valign="top"> <p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">*</span></p></td> <td valign="top"> <p style="text-align:justify;margin-top:2pt;margin-bottom:0pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Less than 10%</p></td></tr></table></div>
CY2021 us-gaap Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
Payments are generally due within three months of completion of the performance obligation and subsequent invoicing and, therefore, do not include significant financing components.
CY2021 syna Account Receivable Bad Debt Charge
AccountReceivableBadDebtCharge
0
CY2021Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
1900000
CY2020Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
400000
CY2021Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
7000000.0
CY2021Q2 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
36100000
CY2020Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3200000
CY2020Q2 us-gaap Contract With Customer Refund Liability
ContractWithCustomerRefundLiability
25800000
CY2021 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
1800000
CY2020 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
2000000.0
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0
CY2020 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
3700000
CY2020Q2 us-gaap Inventory Work In Process And Raw Materials Net Of Reserves
InventoryWorkInProcessAndRawMaterialsNetOfReserves
53600000
CY2020Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
48400000
CY2021Q2 us-gaap Inventory Net
InventoryNet
82000000.0
CY2020Q2 us-gaap Inventory Net
InventoryNet
102000000.0
CY2021 syna Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax
ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax
-1400000
CY2019 syna Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax
ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax
-1100000
CY2020 syna Foreign Currency Transaction Realized And Unrealized Gain Loss Net Of Tax
ForeignCurrencyTransactionRealizedAndUnrealizedGainLossNetOfTax
200000
CY2020Q2 us-gaap Goodwill
Goodwill
360800000
CY2019Q2 us-gaap Goodwill
Goodwill
372800000
CY2021 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
209200000
CY2020 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
0
CY2021 syna Goodwill Allocated To Sale Of Product Line
GoodwillAllocatedToSaleOfProductLine
0
CY2020 syna Goodwill Allocated To Sale Of Product Line
GoodwillAllocatedToSaleOfProductLine
-12000000.0
CY2021Q2 us-gaap Goodwill
Goodwill
570000000.0
CY2020Q2 us-gaap Goodwill
Goodwill
360800000
CY2021 us-gaap Number Of Reporting Units
NumberOfReportingUnits
2
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021Q2 syna Customer Obligation
CustomerObligation
43100000
CY2020Q2 syna Customer Obligation
CustomerObligation
29000000.0
CY2021Q2 syna Accrued Liabilities For Inventory Purchase
AccruedLiabilitiesForInventoryPurchase
17000000.0
CY2020Q2 syna Accrued Liabilities For Inventory Purchase
AccruedLiabilitiesForInventoryPurchase
27900000
CY2021Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
5400000
CY2020Q2 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3900000
CY2021Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
30700000
CY2020Q2 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
30200000
CY2021Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
96200000
CY2020Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
91000000.0
CY2021Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
15400000
CY2020Q2 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
16400000
CY2021Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
27100000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24000000.0
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14600000
CY2021Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
12000000.0
CY2020Q2 us-gaap Other Sundry Liabilities Noncurrent
OtherSundryLiabilitiesNoncurrent
13000000.0
CY2021Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
78500000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
44000000.0
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 us-gaap Net Income Loss
NetIncomeLoss
79600000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
118800000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-22900000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34800000
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
33600000
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34600000
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3500000
CY2020 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1200000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
38300000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34800000
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34600000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.29
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.54
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.66
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.08
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.41
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.66
CY2021Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
222200000
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
215500000
CY2021Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
131000000.0
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
131200000
CY2021Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
91200000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
84300000
CY2021 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
19800000
CY2020 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
16600000
CY2020Q3 us-gaap Business Acquisition Date Of Acquisition Agreement1
BusinessAcquisitionDateOfAcquisitionAgreement1
2020-07-17
CY2020Q3 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1
CY2020Q3 syna Purchase Price Held In Escrow
PurchasePriceHeldInEscrow
3100000
CY2020Q3 us-gaap Business Acquisition Effective Date Of Acquisition1
BusinessAcquisitionEffectiveDateOfAcquisition1
2020-07-31
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2300000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-800000
CY2021Q2 us-gaap Other Long Term Debt
OtherLongTermDebt
1400000
CY2021 us-gaap Fair Value Of Assets Acquired
FairValueOfAssetsAcquired
1700000
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
243200000
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
301500000
CY2020Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
398300000
CY2020Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
304900000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
93400000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
110100000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
51400000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
74400000
CY2021 us-gaap Interest Expense Long Term Debt
InterestExpenseLongTermDebt
5000000.0
CY2021 us-gaap Debt Instrument Convertible Threshold Consecutive Trading Days1
DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
5
CY2021 us-gaap Debt Instrument Convertible Threshold Trading Days
DebtInstrumentConvertibleThresholdTradingDays
5
CY2021 us-gaap Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger
DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
0.98
CY2021Q2 syna Convertible Notes Payable Conversion Request
ConvertibleNotesPayableConversionRequest
19400000
CY2021Q2 syna Senior Notes Redemption In Cash
SeniorNotesRedemptionInCash
19400000
CY2021Q2 syna Conversion Of Notes Into Common Stock
ConversionOfNotesIntoCommonStock
118092
CY2021Q2 syna Loss On Coversion Of Notes
LossOnCoversionOfNotes
300000
CY2021 syna Redemption Of Principal Amout Percentage
RedemptionOfPrincipalAmoutPercentage
1
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
99000000.0
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
86100000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
25900000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
19000000.0
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
18900000
CY2021Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1600000
CY2021Q2 syna Finite Lived Intangible Assets Amortization Expense To Be Determined
FiniteLivedIntangibleAssetsAmortizationExpenseToBeDetermined
51000000.0
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
301500000
CY2021 syna Redemption Of Principal Amout Percentage
RedemptionOfPrincipalAmoutPercentage
1
CY2021Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
5700000
CY2021 syna Percentage Of Voting Capital Stock Of Certain Foreign Subsidiaries Collateralized
PercentageOfVotingCapitalStockOfCertainForeignSubsidiariesCollateralized
0.65
CY2021 syna Percentage Of Non Voting Capital Stock
PercentageOfNonVotingCapitalStock
1
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
The leases expire at various dates through fiscal year 2030, some of which include options to extend the lease for up to 5 years.
CY2021 syna Lease Expiration Year
LeaseExpirationYear
2030
CY2021 us-gaap Operating Lease Expense
OperatingLeaseExpense
10100000
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
31700000
CY2020Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
6500000
CY2021Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
24000000.0
CY2020Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14600000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
33300000
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
21100000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
10000000.0
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
8400000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
21800000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
2900000
CY2021Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P6Y2M4D
CY2021Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0401
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
10000000.0
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
5900000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
4400000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
3800000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
3900000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
9700000
CY2021Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
37700000
CY2021Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4400000
CY2021Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
33300000
CY2021 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10100000
CY2020 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10300000
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2021Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3322989
CY2021Q2 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
5365755
CY2021 us-gaap Stock Issued During Period Shares Treasury Stock Reissued
StockIssuedDuringPeriodSharesTreasuryStockReissued
118092
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3190152
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
1360000
CY2021 syna Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Restricted Stock Units Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsRestrictedStockUnitsGrantsInPeriod
803721
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
101009
CY2021 syna Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Performance Stock Units Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsPerformanceStockUnitsGrantsInPeriod
174231
CY2021 syna Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Adjustments For Performance Stock Units
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAdjustmentsForPerformanceStockUnits
-242651
CY2021 syna Share Based Compensation Arrangement By Share Based Payment Awards Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardsForfeituresInPeriod
615962
CY2021 syna Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Unavailable For Grant Upon Expiration Of Plan
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesUnavailableForGrantUponExpirationOfPlan
-223590
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
3322989
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
93100000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
60400000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59000000.0
CY2021 syna Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense
15200000
CY2020 syna Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense
6300000
CY2019 syna Employee Service Share Based Compensation Tax Benefit Expense From Compensation Expense
EmployeeServiceShareBasedCompensationTaxBenefitExpenseFromCompensationExpense
4300000
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
329786
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
69.78
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
221164
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
69.17
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
53561
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
75.48
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
55061
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
66.68
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
4500000
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
55061
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
66.68
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
4500000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23900000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23900000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5200000
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8600000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
10800000
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
2400000
CY2021 syna Stock Purchases Under Employee Stock Purchase Plan As Compensation Maximum Subject To Legal Restrictions And Limitations
StockPurchasesUnderEmployeeStockPurchasePlanAsCompensationMaximumSubjectToLegalRestrictionsAndLimitations
0.15
CY2021 syna Employee Common Stock Purchases Through Payroll Deductions Under Employee Stock Purchase Plan Price As Percentage Of Fair Market Value
EmployeeCommonStockPurchasesThroughPayrollDeductionsUnderEmployeeStockPurchasePlanPriceAsPercentageOfFairMarketValue
0.85
CY2021 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-8400000
CY2020 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
8100000
CY2019 us-gaap Deferred Foreign Income Tax Expense Benefit
DeferredForeignIncomeTaxExpenseBenefit
-6700000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-8900000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2400000
CY2019 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-15200000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31400000
CY2021 us-gaap Defined Contribution Plan Maximum Annual Contributions Per Employee Amount
DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAmount
19500
CY2021 syna Defined Contribution Plans Eligible Employee Contributions Employees Fifty And Over Annual Limit
DefinedContributionPlansEligibleEmployeeContributionsEmployeesFiftyAndOverAnnualLimit
26000
CY2021 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.25
CY2021 syna Contributions By Employer Matching Contributions
ContributionsByEmployerMatchingContributions
1800000
CY2020 syna Contributions By Employer Matching Contributions
ContributionsByEmployerMatchingContributions
2100000
CY2019 syna Contributions By Employer Matching Contributions
ContributionsByEmployerMatchingContributions
2400000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
120100000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
159400000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-20800000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
4100000
CY2020 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
800000
CY2019 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-4900000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
100000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
36100000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
35400000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
20400000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
40300000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
36200000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
15500000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-500000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-5800000
CY2019 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-8500000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
100000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38600000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
25100000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
33500000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-4400000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
100000
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
5200000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
3000000.0
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
4000000.0
CY2021 syna Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount
3800000
CY2020 syna Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount
-2100000
CY2019 syna Effective Income Tax Rate Reconciliation Share Based Compensation Shortfall Amount
EffectiveIncomeTaxRateReconciliationShareBasedCompensationShortfallAmount
-3300000
CY2021 syna Income Tax Reconciliation Non Deductible Compensation
IncomeTaxReconciliationNonDeductibleCompensation
6400000
CY2020 syna Income Tax Reconciliation Non Deductible Compensation
IncomeTaxReconciliationNonDeductibleCompensation
1900000
CY2019 syna Income Tax Reconciliation Non Deductible Compensation
IncomeTaxReconciliationNonDeductibleCompensation
1100000
CY2021 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3800000
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
6100000
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
6100000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-6700000
CY2020 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
4900000
CY2019 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
1000000.0
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Amortization
IncomeTaxReconciliationNondeductibleExpenseAmortization
700000
CY2021 us-gaap Income Tax Reconciliation Tax Contingencies Foreign
IncomeTaxReconciliationTaxContingenciesForeign
5200000
CY2020 us-gaap Income Tax Reconciliation Tax Contingencies Foreign
IncomeTaxReconciliationTaxContingenciesForeign
700000
CY2019 us-gaap Income Tax Reconciliation Tax Contingencies Foreign
IncomeTaxReconciliationTaxContingenciesForeign
400000
CY2021 us-gaap Income Tax Reconciliation Repatriation Of Foreign Earnings
IncomeTaxReconciliationRepatriationOfForeignEarnings
3500000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
200000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-1400000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
300000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
31400000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
38600000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
300000
CY2021Q2 us-gaap Deferred Tax Assets Capital Loss Carryforwards
DeferredTaxAssetsCapitalLossCarryforwards
200000
CY2021Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
3900000
CY2020Q2 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
4000000.0
CY2020Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1200000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
300000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation
3400000
CY2021Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
800000
CY2020Q2 us-gaap Deferred Compensation Plan Assets
DeferredCompensationPlanAssets
600000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
8800000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
6800000
CY2021Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
39100000
CY2020Q2 us-gaap Deferred Tax Assets Tax Credit Carryforwards General Business
DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
41300000
CY2021Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
6000000.0
CY2020Q2 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
6600000
CY2021Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
7200000
CY2021Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
4300000
CY2020Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
5200000
CY2021Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
70600000
CY2020Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
69100000
CY2021Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
32600000
CY2020Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
33300000
CY2021Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
38000000.0
CY2020Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
35800000
CY2021Q2 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
900000
CY2021Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Interest
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest
3400000
CY2020Q2 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Interest
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInterest
7100000
CY2021Q2 us-gaap Deferred Tax Liabilities Undistributed Foreign Earnings
DeferredTaxLiabilitiesUndistributedForeignEarnings
3500000
CY2021Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
29000000.0
CY2021Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3500000
CY2021Q2 us-gaap Tax Cuts And Jobs Act Of2017 Transition Tax For Accumulated Foreign Earnings Liability
TaxCutsAndJobsActOf2017TransitionTaxForAccumulatedForeignEarningsLiability
2100000
CY2020 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
2500000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20100000
CY2021Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
22600000
CY2020Q2 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
14300000
CY2019Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18900000
CY2018Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
24800000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
3200000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
4200000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
100000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
6200000
CY2019 syna Unrecognized Tax Benefits Decreases Resulting From Remeasurement
UnrecognizedTaxBenefitsDecreasesResultingFromRemeasurement
-2000000.0
CY2020 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
2100000
CY2019 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1900000
CY2020Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
20100000
CY2019Q2 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
18900000
CY2021 syna Increase Decrease In Unrecognized Tax Benefit Income Tax Penalties And Interest Accrued
IncreaseDecreaseInUnrecognizedTaxBenefitIncomeTaxPenaltiesAndInterestAccrued
200000
CY2019 syna Increase Decrease In Unrecognized Tax Benefit Income Tax Penalties And Interest Accrued
IncreaseDecreaseInUnrecognizedTaxBenefitIncomeTaxPenaltiesAndInterestAccrued
700000
CY2021Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1700000
CY2020Q2 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
1900000
CY2021Q2 us-gaap Decrease In Unrecognized Tax Benefits Is Reasonably Possible
DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
3400000
CY2021Q2 us-gaap Increase In Unrecognized Tax Benefits Is Reasonably Possible
IncreaseInUnrecognizedTaxBenefitsIsReasonablyPossible
3000000.0
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021 syna Number Of Product Categories
NumberOfProductCategories
3
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1339600000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1333900000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1472200000
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1339600000
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1333900000
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1472200000
CY2021Q2 us-gaap Noncurrent Assets
NoncurrentAssets
962700000
CY2020Q2 us-gaap Noncurrent Assets
NoncurrentAssets
538500000

Files In Submission

Name View Source Status
0001564590-21-045326-index-headers.html Edgar Link pending
0001564590-21-045326-index.html Edgar Link pending
0001564590-21-045326.txt Edgar Link pending
0001564590-21-045326-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
grcfupkjusni000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
syna-10k_20210626.htm Edgar Link pending
syna-10k_20210626_htm.xml Edgar Link completed
syna-20210626.xsd Edgar Link pending
syna-20210626_cal.xml Edgar Link unprocessable
syna-20210626_def.xml Edgar Link unprocessable
syna-20210626_lab.xml Edgar Link unprocessable
syna-20210626_pre.xml Edgar Link unprocessable
syna-ex103f_249.htm Edgar Link pending
syna-ex103g_250.htm Edgar Link pending
syna-ex21_8.htm Edgar Link pending
syna-ex231_11.htm Edgar Link pending
syna-ex311_7.htm Edgar Link pending
syna-ex312_6.htm Edgar Link pending
syna-ex321_12.htm Edgar Link pending
syna-ex322_13.htm Edgar Link pending